Matinas BioPharma Holdings (MTNB) Cash from Investing Activities (QoQ) (2013 - 2024)
Matinas BioPharma Holdings (MTNB) Cash from Investing Activities (QoQ) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -94.82% |
| Sep 30, 2024 | 428.32% |
| Jun 30, 2024 | -246.90% |
| Mar 31, 2024 | -32.43% |
| Dec 31, 2023 | 173.06% |
| Sep 30, 2023 | -82.51% |
| Jun 30, 2023 | 106.60% |
| Mar 31, 2023 | 7,242.86% |
| Dec 31, 2022 | -100.73% |
| Sep 30, 2022 | 251.64% |
| Jun 30, 2022 | -228.06% |
| Mar 31, 2022 | 5,126.55% |
| Dec 31, 2021 | -76.66% |
| Sep 30, 2021 | -96.83% |
| Jun 30, 2021 | -13.19% |
| Mar 31, 2021 | -3.00% |
| Dec 31, 2020 | 426.94% |
| Sep 30, 2020 | -134.79% |
| Jun 30, 2020 | 114.54% |
| Mar 31, 2020 | -880.58% |